Mustang Bio

+$0.12 (+6.42%) Today
+$0.01 (+0.50%) As of 12:28 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Mustang Bio and other ETFs, options, and stocks.

About MBIO

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of a broad range of proprietary chimeric antigen receptor engineered T cell (CAR T) immunotherapies and gene therapies. It develops CAR T and CRISPR/Cas9-enhanced CAR T therapies across multiple cancers, as well as lentiviral gene therapy for XSCID.

CEO
Manuel Litchman
Employees
62
Headquarters
Worcester, Massachusetts
Founded
2015

MBIO Key Statistics

Market cap
185.92M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.19M
High today
$2.03
Low today
$1.87
Open price
$1.90
Volume
1.29M
52 Week high
$5.22
52 Week low
$1.84

MBIO Earnings

-$0.32
-$0.21
-$0.11
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure